To be considered for the study, patients must be:

  • 18 years of age or older
  • Newly diagnosed with metastatic kidney cancer
  • Good candidates for standard surgery (nephrectomy)
  • Good candidates to receive standard targeted drug therapy

Learn more at ClinicalTrials.gov